Results 231 to 240 of about 334,749 (357)

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

Advanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang, Jingjing Wang, Long Ngo, Li Li, Yuling Wang   +4 more
wiley   +1 more source

Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1. [PDF]

Sci Rep
Mahafujul Alam SS, Mir SA, Samanta A, Nayak B, Ali S, Hoque M.   +5 more
europepmc   +1 more source

CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy. [PDF]

JCI Insight, 2023
Huff AL, Longway G, Mitchell JT, Andaloori L, Davis-Marcisak E, Chen F, Lyman MR, Wang R, Mathew J, Barrett B, Rahman S, Leatherman J, Yarchoan M, Azad NS, Yegnasubramanian S, Kagohara LT, Fertig EJ, Jaffee EM, Armstrong TD, Zaidi N.   +19 more
europepmc   +1 more source

Graphene Oxide‐Based Gene Modulation in Preferential Elimination of Lung Cancer Cells in a 3D Tumor Microenvironment Model

Advanced NanoBiomed Research, EarlyView.
Chemically modified graphene oxide nanocarriers provide a targeted lung cancer gene therapy platform. In a 3D tumor microenvironment model, these nanocarriers deliver therapeutic genes, regulate immune markers, and induce apoptosis in cancer cells. Combined gene delivery enhances cancer cell elimination, demonstrating the potential of this approach for
Francesca Grilli, Sadman Sakib, Fabio Variola, Shan Zou   +3 more
wiley   +1 more source

Human Papillomavirus-Related Cancer Vaccine Strategies. [PDF]

Vaccines (Basel)
Cai X, Xu L.
europepmc   +1 more source

Book Review: Cancer Vaccines and Immunotherapy [PDF]

, 2001
Karen McAdam
openalex   +1 more source

Immunoengineering of a Photocaged 5´‐triphosphate Oligoribonucleotide Ligand for Spatiotemporal Control of RIG‐I Activation in Cancer

Angewandte Chemie International Edition, EarlyView.
This study presents a method for precise control of RIG‐I (retinoic acid inducible gene I), an innate immune receptor of RNA that, when activated, induces anti‐tumor immune responses and cancer cell death. By incorporating photocage modifications into RNA ligands, we enable a spatially and temporally regulated immune response and offer a targeted ...
Sandra Anika Lewash, Vivien Rose McKenney, Christine Wuebben, Janos Ludwig, Racha Hosni, Dirk Radzey, Marieta I. Toma, Eva Bartok, Martin Schlee, Thomas Zillinger, Alexander Heckel, Gunther Hartmann   +11 more
wiley   +1 more source

Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy. [PDF]

NPJ Vaccines
Ke TW, Chen CY, Chen WT, Tsai YY, Chiang SF, Huang CH, Lin YS, Chen TH, Chen TW, Liang JA, Chao KSC, Huang KC.   +11 more
europepmc   +1 more source

Human cancer vaccines

Advanced Drug Delivery Reviews, 2006
Zsuzsanna Tabi, Stephen Man
openaire   +3 more sources

Development of an Organoautocatalyzed Double σ‐Bond C(sp2)‐N Transamination Metathesis Reaction

Angewandte Chemie International Edition, Accepted Article.
The transamination reaction, which involves the conversion of one amine to another, traditionally relies on biological enzyme catalysts. Although chemists have recently developed a few transition metal‐catalyzed methods, mimicking these enzymes to interconvert amine groups in acyclic substrates via transamination metathesis of a single C(sp2)–N bond ...
Volker Klein, Florian Schuster, Jonas Amthor, Harald Maid, Prabhakar Bijalwan, Fahmi Himo, Stefano Santoro, Svetlana B. Tsogoeva   +7 more
wiley   +1 more source